Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.8825
-0.0775 (-8.07%)
At close: Jun 13, 2025, 4:00 PM
0.9450
+0.0625 (7.08%)
After-hours: Jun 13, 2025, 7:59 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.83 million as of June 13, 2025. Its market cap has increased by 76.34% in one year.
Market Cap
3.83M
Enterprise Value
-2.95M
1-Year Change
76.34%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.83M, a decrease of -98.15%. That is a compound annual growth rate of -74.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 3.83M | -60.78% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 357.59B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 229.07B |